Use of an automated apparatus to quantitate mumps virus-and poliovirusneutralizing antibody is described. The automated titration equipment affords savings in effort, time, and reagents in conducting large-scale surveys for the determination of mumps-and poliovirus-neutralizing antibodies. This technique has been found to be reproducible and gives results comparable to other antibody assay methods.
The recent development of an automatic programmable machine (Dynatiter, Cooke Engineering Co., Alexandria, Va.) for performing serial dilutions and dispensing reagents in microtitration plates has been found applicable to automated testing for mumps-and poliovirusneutralizing antibodies. This report describes the necessary modification of this equipment for use in such tests and our experience in comparing these test results with other antibody assay systems.
MATERIALS AND METHODS Microtitration equipment. Microtitration equipment was obtained from a commercial source (Microbiological Associates, Inc., Bethesda, Md.) and consisted of a Dynatiter diluting and dispensing machine, transfer plates, transfer plate holders, microtissue culture plates and lids, 0.025-ml Go-NoGo diluter testers (blotters), 0.025-ml hand diluters, 0.025-ml disposable pipettes, and Microdel dispensing bottles.
The Dynatiter is an automatic, programmable machine equipped with an 8-channel 0.025-ml microdiluter assembly, three independent 8-channel 0.025-ml dispensing manifolds, a diluting head rinsing module, a diluting head flaming unit, and microplate delivery (down stack) and pickup (up stack) modules. To adapt the Dynatiter for transfer plate operation, the manufacturer modified the diluter head cam assembly so that the microdiluters would lower more gently into the transfer plate wells. This modification prevented the loss of diluent through the transfer plate capillary holes. Transfer plate holders were milled to fit within standard microplate lids. By carrying the transfer plate and holder through the machine on an inverted lid, the stacking modules and plate carriers operated without modification, and, in addition, this lid acted as a transparent undersurface which could be examined to detect possible loss of serum-virus mixtures through the capillary holes of the transfer plate. Sera. Human sera stored at -20 C were inactivated at 56 C for 30 min prior to use.
Neutralization test. The microtransfer poliovirus neutralization tests were performed as described by Moritsugu et al. (8) with the modification that microcultures were maintained in M 199 and incubated in 5% CO, in air. The mumps microneutralization test was performed as described by Kenny et al. (4) with the modifications that M 199 was used in place of Earle balanced salt solution, serum dilutions were made in tubes, and all reagents were transferred to the wells using disposable 1-ml glass pipettes.
In the automated microneutralization test, microdiluters were tested prior to use for proper delivery on Go-NoGo testers. The Dynatiter dispensing units were calibrated to deliver 0.025 ml. Serum (0.025 ml) was manually dispensed into the first wells of the already assembled transfer plates with Microdel dispensing bottles or disposable 0.025-ml pipettes. Rinse and blotter reservoirs were placed so that before each series of dilutions the microdiluters were wetted in phosphate-buffered saline and then blotted. Following the serum dilution step, the microdiluters were rinsed and blotted, and the cycle was repeated for the next plate. The transfer plates were stacked in the down-stacking holder and the machine was cycled to perform the following operations: (i) diluent (microtest maintenance medium) was added in 0.025-ml quantities to all wells; (ii) serial twofold dilutions were made; and (iii) 0.025 ml of virus was added to each well. Appropriate virus titrations, serum controls, and cell controls were manually prepared on separate plates. When these operations were completed for all plates, mixtures were incubated at 35 C for 1 h and then inoculated by the microtransfer technique (1) into previously monolayered Vero microtissue culture plates. Cultures were examined for mumps or poliovirus cytopathic effect at day 6 and 7, respectively. End points were calculated by the method of Kdrber (3) and expressed for serum antibodies as log, 50% serum neutralizing antibody titers (SNT5O) per 0.025 ml or for challenge virus log,, 50% tissue culture infectious doses per 0.025 ml.
RESULTS
In Figure 1 , data are presented showing the results of mumps virus microneutralization tests performed by manual and automated techniques on human sera previously classified as antibody negative, or with low or high levels of antibody. Twofold dilution series were made starting at a 1:2 dilution; the autotiter test used a series to two titrations (i.e., two rows of microtiter wells) per serum, whereas three replicate titrations (i.e., three rows of microtiter wells) per serum were done by the manual method. Thiry sera were shown to contain antibodies by both tests. Among this group, antibody levels agreed within a twofold dilution in 25 (83%). Of the remaining five sera, three (10%) gave titers greater than twofold higher in the autotiter system and two (7%) had greater than twofold lower values. Two sera by each test were antibody positive at the 0.5 log2 titer level and negative by the other. Eighteen sera were negative by both methods. Thus, the tests appeared to be of approximately equal sensitivity.
One variable of concern using the autotiter method was the increased time that the challenge virus was exposed to heat and light during the performance of the test. For example, during a 2-h test, sera titrated on the first plate are in the presence of virus 2 h longer than the sera on the last plate. Repeated mumps and poliovirus type 2 autoneutralization tests were conducted with portions from the same serum to determine the effect of test time on neutralizing antibody titers and challenge virus stability. Data are presented in Table 1 Neither contamination nor cell survival has been a problem in the automated microneutralization test. In two typical tests consisting of 8,132 microculture wells in total, only four were contaminated. All were sporadic fungus contaminants that could not be correlated with contaminated sera. Fungal contaminants were easily contained if observed and treated early by adding 1 drop of Thimersol 1:10,000 (Eli Lilly and Co., Indianapolis, Ind.), allowing it to stand for 1 min, and then aspirating well contents. Dehydration of microtissue culture wells was readily prevented over a 7-day incu- (2, (4) (5) (6) (7) (8) (9) . The development of an automated microneutralization test was of great value. In our laboratory, the autotiter method enables two technicians to perform a 60-microculture plate test in 4 to 5 h, including the time required for setting up, incubating, and inoculating. In addition, the autotiter equipment provides a further saving in time and manpower in the processes of dispensing cells and changing nutrient media.
Replicate comparisons of automated and manual microtransfer neutralization techniques indicate that the autotitration procedure gives more reproducible results. Autoneutralization tests for mumps and poliovirus has little day-today or within test variation.
Moritsugu et al. (8) compared poliovirus microtransfer neutralization titers assayed in Vero cells with conventional tube neutralization titers assayed in primary cynomolgus monkey kidney cells. Their results indicate that both systems give comparable results. Our observation that microtransfer by autotitration is more reproducible extends these observations to the use of the autotitration system. The observations reported here concern poliovirus type 2. Parallel experience involving fewer tests with poliovirus types 1 and 3 have given comparable results in our hands. Kenny et al. (3) compared mumps serum neutralization titers by Vero microneutralization with the primary chicken embryo-hemadsorption test performed in tube cultures and found excellent correlation if the tests were read on day 5 or 6 after inoculation. The comparison of mumps virus autoneutralization titers with manual microneutralization titers shows a high degree of correlation. As with all procedures for the determination of mumps antibodies, a few variations were seen in sera containing low levels of antibody. These titer deviations, however, fall well within day-to-day test variance; their frequency in this study was magnified by the intended selection of a large number of antibody-negative sera and sera thought to contain low levels of antibody. A major factor influencing the application of autotiter to other virus microneutralization tests (4) (5) (6) (7) (8) (9) is the stability of the challenge virus for the time period required to complete autotitrations. Currently, automated tests for the detection of antibodies to herpes simplex, varicellazoster, and cytomegaloviruses using the autotiter are being evaluated.
